Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 280

1.

Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment.

Brunello N, den Boer JA, Judd LL, Kasper S, Kelsey JE, Lader M, Lecrubier Y, Lepine JP, Lydiard RB, Mendlewicz J, Montgomery SA, Racagni G, Stein MB, Wittchen HU.

J Affect Disord. 2000 Oct;60(1):61-74. Review.

PMID:
10940449
2.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
3.

WCA recommendations for the long-term treatment of social phobia.

Van Ameringen M, Allgulander C, Bandelow B, Greist JH, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP; World Council of Anxiety..

CNS Spectr. 2003 Aug;8(8 Suppl 1):40-52. Review.

PMID:
14767397
4.

Social phobia: diagnosis, severity and implications for treatment.

Montgomery SA.

Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 1:S1-6. Review.

PMID:
10361959
5.

[Clinical and therapeutic characteristics of social phobia in French psychiatry (Phoenix study)].

PĂ©lissolo A, Huron C, Fanget F, Servant D, Stiti S, Richard-Berthe C, Boyer P.

Encephale. 2006 Jan-Feb;32(1 Pt 1):106-12. French.

PMID:
16633297
6.

New uses for antidepressants: social phobia.

Keck PE Jr, McElroy SL.

J Clin Psychiatry. 1997;58 Suppl 14:32-6; discussion 37-8. Review.

PMID:
9418744
7.

The treatment of childhood social anxiety disorder.

Beidel DC, Ferrell C, Alfano CA, Yeganeh R.

Psychiatr Clin North Am. 2001 Dec;24(4):831-46. Review.

PMID:
11723636
8.

Social phobia: a pharmacologic treatment overview.

Jefferson JW.

J Clin Psychiatry. 1995;56 Suppl 5:18-24. Review.

PMID:
7782272
9.

The psychopharmacology of social phobia and comorbid disorders.

Rosenbaum JF, Pollock RA.

Bull Menninger Clin. 1994 Spring;58(2 Suppl A):A67-83. Review.

PMID:
7913851
10.

The role of drug therapy in social phobia.

Lydiard RB.

J Affect Disord. 1998 Sep;50 Suppl 1:S35-9. Review.

PMID:
9851577
11.

[Short-term effects of a cognitive-behavioural group therapy in social phobia: evaluation of sixty patients].

Camart N, André C, Trybou V, Bourdel MC.

Encephale. 2006 Nov-Dec;32(6 Pt 1):1011-8. French.

PMID:
17372547
12.

Social anxiety disorder: a common, underrecognized mental disorder.

Bruce TJ, Saeed SA.

Am Fam Physician. 1999 Nov 15;60(8):2311-20, 2322. Review.

13.

Drugs in development for social anxiety disorder: more to social anxiety than meets the SSRI.

van Ameringen M, Mancini C, Farvolden P, Oakman J.

Expert Opin Investig Drugs. 2000 Oct;9(10):2215-31. Review.

PMID:
11060802
14.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
15.

Recent developments in the psychopharmacology of social phobia.

Den Boer JA, van Vliet IM, Westenberg HG.

Eur Arch Psychiatry Clin Neurosci. 1995;244(6):309-16. Review.

PMID:
7772614
16.

The pharmacotherapy of social phobia.

Pollack MH, Gould RA.

Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:71-5. Review.

PMID:
8923113
17.

Social anxiety disorder: designing a pharmacologic treatment strategy.

Pollack MH.

J Clin Psychiatry. 1999;60 Suppl 9:20-6.

18.

Spotlight on paroxetine in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL.

CNS Drugs. 2002;16(6):425-34. Review.

PMID:
12027788
19.

Social phobia: everyone's disorder?

Jefferson JW.

J Clin Psychiatry. 1996;57 Suppl 6:28-32. Review.

PMID:
8647795
20.

Medication therapy for social phobia.

Marshall RD, Schneier FR, Fallon BA, Feerick J, Liebowitz MR.

J Clin Psychiatry. 1994 Jun;55 Suppl:33-7. Review.

PMID:
8077172

Supplemental Content

Support Center